|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 25, 22430-22437, June 21, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Mitochondrial ferritin (MtF) is a newly
identified ferritin encoded by an intronless gene on chromosome 5q23.1.
The mature recombinant MtF has a ferroxidase center and binds iron
in vitro similarly to H-ferritin. To explore the structural
and functional aspects of MtF, we expressed the following forms in HeLa
cells: the MtF precursor (~28 kDa), a mutant MtF precursor with a
mutated ferroxidase center, a truncated MtF lacking the ~6-kDa
mitochondrial leader sequence, and a chimeric H-ferritin with this
leader sequence. The experiments show that all constructs with the
leader sequence were processed into ~22-kDa subunits that assembled
into multimeric shells electrophoretically distinct from the cytosolic
ferritins. Mature MtF was found in the matrix of mitochondria, where it
is a homopolymer. The wild type MtF and the mitochondrially targeted H-ferritin both incorporated the 55Fe label in
vivo. The mutant MtF with an inactivated ferroxidase center did
not take up iron, nor did the truncated MtF expressed transiently in
cytoplasm. Increased levels of MtF both in transient and in stable
transfectants resulted in a greater retention of iron as MtF in
mitochondria, a decrease in the levels of cytosolic ferritins, and
up-regulation of transferrin receptor. Neither effect occurred with the
mutant MtF with the inactivated ferroxidase center. Our results
indicate that exogenous iron is as available to mitochondrial ferritin
as it is to cytosolic ferritins and that the level of MtF expression
may have profound consequences for cellular iron homeostasis.
Human Mitochondrial Ferritin Expressed in HeLa Cells Incorporates
Iron and Affects Cellular Iron Metabolism*
,
,
,
, and
Section of Chemistry, Faculty of Medicine,
University of Brescia, Brescia, 25100 Italy,
§ Department of Biological and Technological
Research, Istituto di Ricovero e Cura a Carattere Scientifico
(IRCCS) H. San Raffaele, Milano, 20132 Italy, and the ¶ Department
of Biochemistry, Tufts University School of Medicine,
Boston, Massachusetts 02111
*
This work was partially supported by grants from the Italian
Ministry of the University and Research (MIUR) and Cofin-2000, Cofin-2001 (to P. A.), by Consiglio Nazionale delle Ricerche
Targeted Project in Biotechnology (to P. A.), by Telethon-Italy Grant
GP0001Y01 (to S. L.), by Consiglio Nazionale delle
Ricerche-Agenzia2000 (to S. L. and P. A.), and by a grant from the
Tufts University School of Medicine (to J. D.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Protein
Engineering Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) H. San Raffaele, Via Olgettina 58, 20132 Milano, Italy. Tel.:
39-02-2643-4755; Fax: 39-02-2643-4844; E-mail:
levi.sonia@hsr.it.
This article has been cited by other articles:
![]() |
P. Santambrogio, G. Biasiotto, F. Sanvito, S. Olivieri, P. Arosio, and S. Levi Mitochondrial Ferritin Expression in Adult Mouse Tissues J. Histochem. Cytochem., November 1, 2007; 55(11): 1129 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Camaschella, A. Campanella, L. De Falco, L. Boschetto, R. Merlini, L. Silvestri, S. Levi, and A. Iolascon The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload Blood, August 15, 2007; 110(4): 1353 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cavadini, G. Biasiotto, M. Poli, S. Levi, R. Verardi, I. Zanella, M. Derosas, R. Ingrassia, M. Corrado, and P. Arosio RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload Blood, April 15, 2007; 109(8): 3552 - 3559. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nie, G. Chen, A. D. Sheftel, K. Pantopoulos, and P. Ponka In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin Blood, October 1, 2006; 108(7): 2428 - 2434. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Missirlis, S. Holmberg, T. Georgieva, B. C. Dunkov, T. A. Rouault, and J. H. Law Characterization of mitochondrial ferritin in Drosophila PNAS, April 11, 2006; 103(15): 5893 - 5898. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iwasaki, E. L. MacKenzie, K. Hailemariam, K. Sakamoto, and Y. Tsuji Hemin-Mediated Regulation of an Antioxidant-Responsive Element of the Human Ferritin H Gene and Role of Ref-1 during Erythroid Differentiation of K562 Cells. Mol. Cell. Biol., April 1, 2006; 26(7): 2845 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Davies, Y. S. Rahmanto, C. R. Chitambar, and D. R. Richardson Resistance to the Antineoplastic Agent Gallium Nitrate Results in Marked Alterations in Intracellular Iron and Gallium Trafficking: Identification of Novel Intermediates J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 153 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alberghini, S. Recalcati, L. Tacchini, P. Santambrogio, A. Campanella, and G. Cairo Loss of the von Hippel Lindau Tumor Suppressor Disrupts Iron Homeostasis in Renal Carcinoma Cells J. Biol. Chem., August 26, 2005; 280(34): 30120 - 30128. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Napier, P. Ponka, and D. R. Richardson Iron trafficking in the mitochondrion: novel pathways revealed by disease Blood, March 1, 2005; 105(5): 1867 - 1874. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nie, A. D. Sheftel, S. F. Kim, and P. Ponka Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis Blood, March 1, 2005; 105(5): 2161 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Campanella, G. Isaya, H. A. O'Neill, P. Santambrogio, A. Cozzi, P. Arosio, and S. Levi The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast Hum. Mol. Genet., October 1, 2004; 13(19): 2279 - 2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Kwok and D. R. Richardson Examination of the Mechanism(s) Involved in Doxorubicin-Mediated Iron Accumulation in Ferritin: Studies Using Metabolic Inhibitors, Protein Synthesis Inhibitors, and Lysosomotropic Agents Mol. Pharmacol., January 1, 2004; 65(1): 181 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cazzola, R. Invernizzi, G. Bergamaschi, S. Levi, B. Corsi, E. Travaglino, V. Rolandi, G. Biasiotto, J. Drysdale, and P. Arosio Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia Blood, March 1, 2003; 101(5): 1996 - 2000. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Park, O. Gakh, S. M. Mooney, and G. Isaya The Ferroxidase Activity of Yeast Frataxin J. Biol. Chem., October 4, 2002; 277(41): 38589 - 38595. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |